Clinical Trial Details
| Trial ID: | L2285 |
| Source ID: | NCT02807974 |
| Associated Drug: | Cs-3150 |
| Title: | Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Hypertension |
| Interventions: | DRUG: CS-3150 |
| Outcome Measures: | Primary: Change from baseline in sitting systolic and diastolic blood pressure, Change from baseline in sitting systolic and diastolic blood pressure, Baseline to end of Week 12 | Secondary: Time course of systolic and diastolic blood pressure, Time course of systolic and diastolic blood pressure, Baseline to end of Week 12|Proportion of patients achieving blood pressure control, Proportion of patients achieving blood pressure control, Baseline to end of Week 12|Change rate from baseline in urine-albumin-to-creatinine ratio, Change rate from baseline in urine-albumin-to-creatinine ratio., Baseline to end of Week 12|Time course of urine-albumin-to-creatinine ratio, Time course of urine-albumin-to-creatinine ratio., Baseline to end of Week 12 |
| Sponsor/Collaborators: | Sponsor: Daiichi Sankyo Co., Ltd. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 51 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2016-06 |
| Completion Date: | 2017-03 |
| Results First Posted: | |
| Last Update Posted: | 2018-12-21 |
| Locations: | Sanuki-shi, Kagawa, Japan |
| URL: | https://clinicaltrials.gov/show/NCT02807974 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|